Long COVID
From the Journals
Immune response may explain brain damage after COVID-19
Antibodies appear involved in an attack on the cells lining the brain’s blood vessels.
Feature
Does your patient have long COVID? Some clues on what to look for
Long COVID is known by many different names: long-haul COVID, postacute COVID-19, or even chronic COVID.
From the Journals
Long COVID-19 in children and adolescents: What do we know?
“The message we want to give is that long COVID-19 exists, it’s happening in children and adolescents, and patients need this recognition. And...
Guidelines
ACC/AHA issue clinical lexicon for complications of COVID-19
The document standardizes definitions for cardiovascular and noncardiovascular complications and sets out a framework to capture and better...
From the Journals
Noninvasive brain stimulation promising for COVID-related smell loss
Conference Coverage
Diabetes tied to risk of long COVID, too
Roughly 43% of studies in a literature review identified diabetes as a risk factor for postacute sequelae of COVID-19.
Conference Coverage
‘Alarming’ new data on disordered sleep after COVID-19
More than two-thirds of patients (67.2%) reported at least moderate fatigue, while 21.8% reported severe fatigue.
From the Journals
CDC says about 20% get long COVID. New models try to define it
“Those numbers are high and it’s alarming. But we’ve been sounding the alarm for quite some time, and we’ve been assuming that about one in five...
Conference Coverage
Long COVID neuropsychiatric deficits greater than expected
Studies document the cognitive and psychiatric effects of long COVID.
From the Journals
Most COVID long-haulers suffer long-term debilitating neurologic symptoms
From the Journals
Neuropsychiatric risks of COVID-19: New data
“Neuropsychological sequelae need to be considered after all severe respiratory infections, rather than only following severe COVID-19,” said Dr....